A detailed history of Ubs Group Ag transactions in Insulet Corp stock. As of the latest transaction made, Ubs Group Ag holds 116,880 shares of PODD stock, worth $31.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
116,880
Previous 115,620 1.09%
Holding current value
$31.1 Million
Previous $23.3 Million 16.59%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$180.69 - $239.01 $227,669 - $301,152
1,260 Added 1.09%
116,880 $27.2 Million
Q2 2024

Aug 13, 2024

BUY
$161.02 - $206.98 $153,452 - $197,251
953 Added 0.83%
115,620 $23.3 Million
Q1 2024

May 13, 2024

BUY
$163.6 - $209.11 $8.71 Million - $11.1 Million
53,263 Added 86.74%
114,667 $19.7 Million
Q4 2023

Feb 09, 2024

BUY
$127.77 - $221.42 $68,356 - $118,459
535 Added 0.88%
61,404 $13.3 Million
Q3 2023

Nov 09, 2023

BUY
$154.67 - $290.89 $17,013 - $31,997
110 Added 0.18%
60,869 $9.71 Million
Q2 2023

Aug 11, 2023

SELL
$272.48 - $330.23 $5.06 Million - $6.13 Million
-18,555 Reduced 23.39%
60,759 $17.5 Million
Q1 2023

May 12, 2023

BUY
$276.36 - $326.03 $16.1 Million - $19 Million
58,230 Added 276.18%
79,314 $25.3 Million
Q4 2022

Feb 08, 2023

SELL
$212.22 - $313.46 $3.77 Million - $5.57 Million
-17,757 Reduced 45.72%
21,084 $6.21 Million
Q3 2022

Nov 10, 2022

BUY
$224.6 - $281.45 $4.65 Million - $5.83 Million
20,706 Added 114.18%
38,841 $8.91 Million
Q2 2022

Aug 10, 2022

SELL
$186.4 - $279.02 $198,516 - $297,156
-1,065 Reduced 5.55%
18,135 $3.95 Million
Q1 2022

May 16, 2022

SELL
$194.8 - $275.7 $5.32 Million - $7.53 Million
-27,306 Reduced 58.72%
19,200 $5.12 Million
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $4.11 Million - $5.12 Million
16,088 Added 52.89%
46,506 $12.4 Million
Q3 2021

Nov 15, 2021

SELL
$260.36 - $307.27 $3.13 Million - $3.69 Million
-12,005 Reduced 28.3%
30,418 $8.65 Million
Q2 2021

Aug 13, 2021

SELL
$225.52 - $304.06 $3.17 Million - $4.27 Million
-14,056 Reduced 24.89%
42,423 $11.6 Million
Q1 2021

May 12, 2021

SELL
$235.95 - $293.05 $17.8 Million - $22.1 Million
-75,505 Reduced 57.21%
56,479 $14.7 Million
Q4 2020

Feb 11, 2021

BUY
$215.97 - $265.89 $18.9 Million - $23.2 Million
87,363 Added 195.79%
131,984 $33.7 Million
Q3 2020

Nov 12, 2020

SELL
$192.55 - $236.59 $1.46 Million - $1.79 Million
-7,567 Reduced 14.5%
44,621 $10.6 Million
Q2 2020

Jul 31, 2020

BUY
$159.17 - $224.73 $2.7 Million - $3.81 Million
16,935 Added 48.04%
52,188 $10.1 Million
Q1 2020

May 01, 2020

SELL
$130.01 - $216.44 $139,890 - $232,889
-1,076 Reduced 2.96%
35,253 $5.84 Million
Q4 2019

Feb 14, 2020

SELL
$144.81 - $186.0 $1.58 Million - $2.03 Million
-10,889 Reduced 23.06%
36,329 $6.22 Million
Q3 2019

Nov 14, 2019

BUY
$117.35 - $167.95 $1.57 Million - $2.25 Million
13,392 Added 39.59%
47,218 $7.79 Million
Q2 2019

Aug 14, 2019

SELL
$82.13 - $120.73 $43,036 - $63,262
-524 Reduced 1.53%
33,826 $4.04 Million
Q1 2019

May 14, 2019

BUY
$72.44 - $101.87 $755,983 - $1.06 Million
10,436 Added 43.64%
34,350 $3.27 Million
Q4 2018

Feb 14, 2019

BUY
$73.27 - $105.19 $1.13 Million - $1.62 Million
15,384 Added 180.35%
23,914 $1.9 Million
Q3 2018

Nov 14, 2018

BUY
$81.43 - $108.13 $81,430 - $108,130
1,000 Added 13.28%
8,530 $904,000
Q2 2018

Aug 14, 2018

SELL
$83.27 - $101.93 $262,883 - $321,793
-3,157 Reduced 29.54%
7,530 $646,000
Q1 2018

May 15, 2018

BUY
$68.49 - $87.2 $483,744 - $615,893
7,063 Added 194.9%
10,687 $926,000
Q4 2017

Feb 14, 2018

BUY
$55.67 - $71.8 $1,391 - $1,795
25 Added 0.69%
3,624 $250,000
Q3 2017

Nov 14, 2017

BUY
$49.68 - $59.46 $50,127 - $59,995
1,009 Added 38.96%
3,599 $199,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,414 Added 120.24%
2,590 $133,000
Q1 2017

Nov 14, 2017

BUY
N/A
1,176
1,176 $51,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.